home · filing · 0001828791-24-000030
8-K filed June 10, 2024, 7:59 PM ET
ticker DSP
CIK 0001828791
regulatory
confidence high
sentiment negative
materiality 0.60
Viant audit committee falls below Nasdaq minimum after director resignation; cure period granted
Viant Technology Inc.
Director Elizabeth Williams resigned from board and audit committee effective June 5, 2024, not due to any disagreement.
Nasdaq notified Viant on June 7, 2024, that audit committee has only two independent directors, violating Rule 5605(c)(2).
Company has cure period until earlier of 2025 annual meeting or June 5, 2025; intends to appoint additional independent director.
Annual meeting results: stockholders elected Tim Vanderhook and Vivian Yang as Class III directors and ratified Deloitte & Touche as auditor.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Departed
Elizabeth Williams
Director
DSP ·
Viant Technology Inc.
Effective 2024-06-05
Filed June 10, 2024, 7:59 PM ET
The disclosure under “Director Resignation” in Item 3.01 above is incorporated by reference into this Item 5.02.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.7
Elizabeth Williams resigned as Director at Viant Technology Inc..
Action resigned
Role Director
Exact text from the filing
The disclosure under “Director Resignation” in Item 3.01 above is incorporated by reference into this Item 5.02.
View on SEC.gov
Source: SEC EDGAR
accession 0001828791-24-000030
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.